Literature DB >> 3674054

Septic bursitis in immunocompromised patients.

R A Roschmann1, C L Bell.   

Abstract

A retrospective analysis of 29 patients with septic bursitis was undertaken to ascertain if immunocompromised patients differed in their clinical presentations, type of organisms cultured, and outcome when compared with their non-immunocompromised cohorts. Thirty episodes of septic bursitis occurred in 29 patients, 43 percent of which occurred in immunocompromised patients. Despite similar clinical presentations, the bursae of immunocompromised patients took three times longer to sterilize and had a much higher bursal white blood cell count when compared with the bursae of non-immunocompromised patients. The bacteriologic spectrum was essentially identical in both groups; there were no cases in which gram-negative organisms were recovered from infected bursae. No cases of septic bursitis were seen in neutropenic patients. The most common factors contributing to an immunocompromised state were alcoholism or steroid therapy. A successful resolution of septic bursitis was seen in all the patients in the immunocompromised groups.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3674054     DOI: 10.1016/0002-9343(87)90895-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

Review 1.  Olecranon bursitis: a systematic overview.

Authors:  John R Blackwell; Bruce A Hay; Alexander M Bolt; Stuart M Hay
Journal:  Shoulder Elbow       Date:  2014-05-06

2.  Septic and non-septic olecranon bursitis in the accident and emergency department--an approach to management.

Authors:  I M Stell
Journal:  J Accid Emerg Med       Date:  1996-09

3.  Clinical characteristics and outcomes of septic bursitis.

Authors:  Sarah B Lieber; Mary Louise Fowler; Clara Zhu; Andrew Moore; Robert H Shmerling; Ziv Paz
Journal:  Infection       Date:  2017-05-29       Impact factor: 3.553

Review 4.  Lower limb complications of diabetes mellitus: a comprehensive review with clinicopathological insights from a dedicated high-risk diabetic foot multidisciplinary team.

Authors:  P Naidoo; V J Liu; M Mautone; S Bergin
Journal:  Br J Radiol       Date:  2015-06-25       Impact factor: 3.039

5.  Management of acute bursitis: outcome study of a structured approach.

Authors:  I M Stell
Journal:  J R Soc Med       Date:  1999-10       Impact factor: 5.344

6.  Olecranon Bursitis Caused by Candida parapsilosis in a Patient with Rheumatoid Arthritis.

Authors:  Carla F Gamarra-Hilburn; Grissel Rios; Luis M Vilá
Journal:  Case Rep Rheumatol       Date:  2016-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.